Understand the source comparison
SS-LUP-332 vs Research Peptides: Mechanism and Application Comparison
GLP-1 Agonists (semaglutide, tirzepatide) GLP-1 receptor activation; slows gastric emptying Appetite suppression, weight loss via caloric deficit Hypothalamus, GI tract High. Addresses different failure points (intake vs cellular efficiency) Complementary. GLP
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- GLP-1 Agonists (semaglutide, tirzepatide)
- GLP-1 receptor activation; slows gastric emptying
- Appetite suppression, weight loss via caloric deficit
- Hypothalamus, GI tract
- High. Addresses different failure points (intake vs cellular efficiency)
- Complementary. GLP-1 creates deficit; SS-LUP-332 maintains metabolic function during restriction.
- GH Secretagogues (GHRP-2, MK-677)
- Stimulates pituitary GH release; elevates IGF-1
- Increased lean mass, improved recovery, anabolic signaling
- Systemic (muscle, bone, connective tissue)
- High. Anabolic + cellular quality control. Separate dosing windows to avoid GH-induced autophagy suppression.
- Synergistic when timed correctly. GH builds tissue; SS-LUP-332 clears damaged components.
- mTOR Inhibitors (rapamycin analogs)
- Inhibits mTOR; blocks nutrient-sensing pathway
- Autophagy activation, lifespan extension in models
- Systemic; affects protein synthesis broadly
- Moderate. Both activate autophagy. Rapamycin's broader effects may overlap or interfere.
- Redundant in autophagy activation. Rapamycin suppresses anabolism; SS-LUP-332 doesn't.
- NAD+ Precursors (NMN, NR)
- Elevates NAD+; activates sirtuins
- Improved mitochondrial function, energy metabolism
- Mitochondria-rich tissues (muscle, liver, brain)
- Very high. NAD+ fuels the energy-dependent steps of mitophagy SS-LUP-332 initiates
- Highly synergistic. SS-LUP-332 signals mitophagy; NAD+ provides capacity to execute it.
- Cognitive Peptides (Semax, Selank)
- BDNF upregulation; modulates neurotransmitter systems
- Improved focus, reduced anxiety, neuroprotection
- Central nervous system
- Moderate. SS-LUP-332's neuroinflammation reduction may complement cognitive effects
- Independent mechanisms. Combining addresses neuroinflammation (SS-LUP-332) and neurotransmitter signaling (cognitive peptides).